Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling

Author:

Saber Sameh,El-Fattah Eslam E. Abd,Abdelhamid Amir Mohamed,Mourad Ahmed A.E.,Hamouda Manal Ali Mahrous,Elrabat Amr,Zakaria Sahar,Haleem Amira A.,Mohamed Sherin Z.,Elgharabawy Rehab Mohamed,Morsy Nesreen Elsayed,El Adle Khalaf Noura,Mohammed Osama A.,El-Bahouty Waleed Barakat,Mostafa Sally Abdallah,Abdelhady Rasha,Galal Omneya,ElSaid Zeinab H.,Yahya Galal,Shata Ahmed,Youssef Mahmoud E.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference83 articles.

1. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment;Schneider;Nat. Commun.,2022

2. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021

3. Risk factors for developing hepatocellular carcinoma in Egypt;Omar;Chin. Clin. Oncol.,2013

4. Blockade of PGE2, PGD2 receptors confers protection against prepatent schistosomiasis mansoni in mice;Abdel-Ghany;J. Egypt. Soc. Parasitol.,2015

5. Hepatocellular Carcinoma (HCC) in Egypt: a comprehensive overview;Rashed;J. Egypt. Natl. Cancer Inst.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3